51 related articles for article (PubMed ID: 22176829)
1. [Breast cancer risk through assessment tool of breast cancer risk].
Carrillo-Barreras RL; Baza-Salinas JG; Rodríguez-Ledesma Mde L
Rev Med Inst Mex Seguro Soc; 2011; 49(6):655-8. PubMed ID: 22176829
[TBL] [Abstract][Full Text] [Related]
2. Model for individualized prediction of breast cancer risk after a benign breast biopsy.
Pankratz VS; Degnim AC; Frank RD; Frost MH; Visscher DW; Vierkant RA; Hieken TJ; Ghosh K; Tarabishy Y; Vachon CM; Radisky DC; Hartmann LC
J Clin Oncol; 2015 Mar; 33(8):923-9. PubMed ID: 25624442
[TBL] [Abstract][Full Text] [Related]
3. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance.
Quante AS; Whittemore AS; Shriver T; Strauch K; Terry MB
Breast Cancer Res; 2012 Nov; 14(6):R144. PubMed ID: 23127309
[TBL] [Abstract][Full Text] [Related]
5. Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: results from a prospective population-based study in France.
Bonadona V; Sinilnikova OM; Chopin S; Antoniou AC; Mignotte H; Mathevet P; Brémond A; Martin A; Bobin JY; Romestaing P; Raudrant D; Rudigoz RC; Léoné M; Chauvin F; Easton DF; Lenoir GM; Lasset C
Genes Chromosomes Cancer; 2005 Aug; 43(4):404-13. PubMed ID: 15887246
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
7. Evaluating breast cancer risk projections for Hispanic women.
Banegas MP; Gail MH; LaCroix A; Thompson B; Martinez ME; Wactawski-Wende J; John EM; Hubbell FA; Yasmeen S; Katki HA
Breast Cancer Res Treat; 2012 Feb; 132(1):347-53. PubMed ID: 22147080
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk assessment: positive predictive value of family history as a predictor of risk.
Smith RP; Ni X; Muram D
Menopause; 2011 Jun; 18(6):621-4. PubMed ID: 21343830
[TBL] [Abstract][Full Text] [Related]
9. Validation of breast cancer risk assessment tools on a French-Canadian population-based cohort.
Jantzen R; Payette Y; de Malliard T; Labbé C; Noisel N; Broët P
BMJ Open; 2021 Apr; 11(4):e045078. PubMed ID: 33846154
[TBL] [Abstract][Full Text] [Related]
10. Breast cancer risk assessment in indigent women at a public hospital.
Abu-Rustum NR; Herbolsheimer H
Gynecol Oncol; 2001 May; 81(2):287-90. PubMed ID: 11330964
[TBL] [Abstract][Full Text] [Related]
11. Validation of two US breast cancer risk prediction models in German women.
Hüsing A; Quante AS; Chang-Claude J; Aleksandrova K; Kaaks R; Pfeiffer RM
Cancer Causes Control; 2020 Jun; 31(6):525-536. PubMed ID: 32253639
[TBL] [Abstract][Full Text] [Related]
12. At pill's 30th birthday, breast cancer question is unresolved.
Althaus FA; Kaeser L
Fam Plann Perspect; 1990; 22(4):173-6. PubMed ID: 2226748
[TBL] [Abstract][Full Text] [Related]
13. Estimating age-specific breast cancer risks: a descriptive tool to identify age interactions.
Anderson WF; Matsuno RK; Sherman ME; Lissowska J; Gail MH; Brinton LA; Yang XR; Peplonska B; Chen BE; Rosenberg PS; Chatterjee N; Szeszenia-Dabrowska N; Bardin-Mikolajczak A; Zatonski W; Devesa SS; García-Closas M
Cancer Causes Control; 2007 May; 18(4):439-47. PubMed ID: 17216325
[TBL] [Abstract][Full Text] [Related]
14. Management of women at increased risk for breast cancer: preliminary results from a new program.
Chart PL; Franssen E
CMAJ; 1997 Nov; 157(9):1235-42. PubMed ID: 9361645
[TBL] [Abstract][Full Text] [Related]
15. Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.
Cuenca RE; Giachino J; Arredondo MA; Hempling R; Edge SB
Cancer; 1996 May; 77(10):2058-63. PubMed ID: 8640670
[TBL] [Abstract][Full Text] [Related]
16. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
Tryggvadottir L; Sigvaldason H; Olafsdottir GH; Jonasson JG; Jonsson T; Tulinius H; Eyfjörd JE
J Natl Cancer Inst; 2006 Jan; 98(2):116-22. PubMed ID: 16418514
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic mastectomy in BRCA1/2 mutation carriers and women at risk of hereditary breast cancer: long-term experiences at the Rotterdam Family Cancer Clinic.
Heemskerk-Gerritsen BA; Brekelmans CT; Menke-Pluymers MB; van Geel AN; Tilanus-Linthorst MM; Bartels CC; Tan M; Meijers-Heijboer HE; Klijn JG; Seynaeve C
Ann Surg Oncol; 2007 Dec; 14(12):3335-44. PubMed ID: 17541692
[TBL] [Abstract][Full Text] [Related]
18. [Is the Gail model for breast cancer risk assessment valid for the Bulgarian women?].
Baitchev G; Christova P; Ivanov I
Khirurgiia (Sofiia); 2009; (6):27-30. PubMed ID: 20506776
[TBL] [Abstract][Full Text] [Related]
19. Timing of familial breast cancer in sisters.
Rebora P; Czene K; Reilly M
J Natl Cancer Inst; 2008 May; 100(10):721-7. PubMed ID: 18477799
[TBL] [Abstract][Full Text] [Related]
20. Applicability of the Gail model for breast cancer risk assessment in Turkish female population and evaluation of breastfeeding as a risk factor.
Ulusoy C; Kepenekci I; Kose K; Aydintug S; Cam R
Breast Cancer Res Treat; 2010 Apr; 120(2):419-24. PubMed ID: 19760030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
